PSCH Fees and Costs — Invesco S&P SmallCap Health Care ETF
Data updated: 2026-07-28
The net expense ratio is 0.29%. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $31K in broker commissions, 0.0186% of average net assets, and portfolio turnover was 42%.
PSCH Fees and Expenses
Annual operating expenses and sales charges of PSCH. Prospectus, as of December 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.29% |
| 12b-1 fee | — |
| Other expenses | 0.00% |
| Gross expense ratio | 0.29% |
| Fee waiver | — |
| Net expense ratio | 0.29% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
PSCH Costs Over Time
On $10,000 invested in PSCH, assuming 5% a year before costs, total costs come to $196 over 5 years, cutting the return by 0.32% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.29%) | $30 | $96 | $167 |
| Trading costs (broker commissions) | $2 | $6 | $11 |
| Lost growth on money paid in costs | $0 | $5 | $18 |
| Total costs | $32 | $107 | $196 |
| Value after costs | $10,468 | $11,469 | $12,567 |
| Impact on return, per year | 0.32% | 0.32% | 0.32% |
PSCH Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending August 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0186%
- Total broker commissions: $31K
- Bought from dealers (principal trades, not a cost): $56.9M
- Portfolio turnover (prospectus): 42%
- Securities on loan, average value: $51.7M
- Net income from securities lending: $65K (0.039% of average net assets)
PSCH Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| INVESCO CAPITAL MARKETS, INC. | $23K | 75.47% |
| COWEN AND COMPANY | $4K | 13.02% |
| JEFFERIES LLC | $1K | 4.65% |
| CITADEL SECURITIES LLC | $849 | 2.75% |
| MORGAN STANLEY & CO. LLC | $538 | 1.74% |
| MACQUARIE CAPITAL (USA) INC. | $501 | 1.62% |
| CITIGROUP GLOBAL MARKETS INC. | $135 | 0.44% |
| BARCLAYS CAPITAL INC. | $57 | 0.18% |
| EVERCORE GROUP L.L.C. | $29 | 0.09% |
| STATE STREET GLOBAL MARKETS, LLC | $10 | 0.03% |
PSCH Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| CITADEL SECURITIES LLC | $15.9M | 28.03% |
| MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | $14.1M | 24.86% |
| ABN AMRO CLEARING CHICAGO LLC | $13.2M | 23.22% |
| GOLDMAN, SACHS & CO. | $6.4M | 11.28% |
| VIRTU AMERICAS LLC | $2.4M | 4.18% |
| BNY MELLON CAPITAL MARKETS, LLC | $2.1M | 3.67% |
| JANE STREET CAPITAL, LLC | $1.8M | 3.20% |
| RBC CAPITAL MARKETS, LLC | $889K | 1.56% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.